The stocks of Surface Oncology, Inc. (NASDAQ:SURF) has been Initiated to Outperform by Robert W. Baird in its latest research note that was published on September 19. The stock also received a Neutral rating from Goldman with the price target of $17. This was contained in a research note published by the firm on May 14. The stock received a Outperform rating and a price target of $26 in Evercore ISI’s research note that was published on May 14.
Surface’s stock is covered by 5 analysts, with 3 of them rating the stock as Buy. It has been deemed to have strong buy by 1 of the analysts, 1 of them have rated it as a Hold while none of them rated it as sell. Meanwhile, none analyst(s) rated it as a sell. The above data shows that SURF has an average analyst rating of Overweight.
Surface Oncology, Inc., which has current market capitalization of above $51 Million, published its last quarter earnings on September 30, 2019. The company was able to amass $344 Million in revenue, which saw a quarterly growth rate of -80.12 percent. During that quarter of the year, Surface also recorded $-0.61 earnings per share (EPS) which is $-0.03 above the $-0.58 estimated by the analysts, leading to a surprise factor of -5.17%.
SURF surged by $0.02 during the normal trading session on Monday and reaching a high of $2.12 during the day while it closed the day at $1.93. The Surface stock had a low trading volume of 0.07 million shares on that day, which is low compared to the average daily volume of 84.57M shares. SURF has also lost 17.17% of its value over the past 7 days. However, the stock has declined by 3.50% in the 3 months of the year. Over the past six months meanwhile, it has lost 51.26% while it has lost 54.48% year-on date.
Shares in AdvanSix Inc. (NYSE:ASIX) fell by -0.10 percent on Monday. The company’s stock began trading at $20.21 below the previous closing price of $20.23, and finished the day at $19.73. Let us now take a look at the stock’s potential support and resistance levels. The publicly traded company was seen to have slipped by -27.52% from its 3 months high price. However, taking another look at ASIX will indicate that it is trading +3.14% away from its 90-day low. Looking at the bigger picture, the AdvanSix Inc. stock has dropped by -43.5% from its 52-week high while it has surged by +3.14% from its 52-week low price.
On November 26, 2019 Sansone Daniel F, Director bought 5,000 shares of the company. The average price for that transaction was $20.28 per share, which meant that Sansone Daniel F spent $101,400.00 purchasing the stocks. The purchase was made public, with the document of the transaction filed with the SEC. Another insider trading occurred, with Director, Marberry Michael purchasing 4,350 shares of this stock on August 14, 2019. The average purchasing price for the stock was $21.34 per share, with the purchased stock accruing $92,829.00. Following this transaction, the insider now holds 39,996 shares of the company, which is worth around $83,991.60.
Let us now take a quick look at the stock’s short, medium and long-term indicators. Composite Indicator shows that ASIX stock was rated as a Sell by TrendSpotter. Its short-term indicators reveal that AdvanSix has a 20-day average volume of 154095 shares. This has led to the ASIX price forecast being placed as a 100% Sell on an average basis. In the medium term, however, the ASIX stock has its 50-Day average volume of 144984 shares, with the indicators also rating it as a 100% Sell. Finally, in the long-term, the ASIX stocks have a 100-Day average volume of 145896 shares, with the long-term indicators rating the stock as just 100% Sell.
AdvanSix has around 10 Million cash on their books at the moment. This figure will have to be compared and looked into, with their current liabilities standing at $287 Million. The AdvanSix stock is bringing in revenue of over 12 months, which is roughly 1 Billion. Despite all that, AdvanSix Inc. is seeing things declining very much as their y-o-y quarterly revenue dropped by -15.74%.
Looking at the stock’s Technical analysis information over the past 50 days shows that its Raw Stochastic average stood at 8.32%. This figure is worse than the company’s 20-day Raw Stochastic average which currently stands at 10.49%. Over the past 20 days, AdvanSix’s Stochastic %K stood at 15.27% while its Stochastic %D was revealed to be 16.24%.